Zeke Capital Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,573
| Closed | -$443K | – | 338 |
|
|
2021
Q3 | $443K | Sell |
2,573
-59
| -2% | -$10.2K | 0.03% | 158 |
|
|
2021
Q2 | $330K | Buy |
2,632
+226
| +9% | +$28.3K | 0.02% | 193 |
|
|
2021
Q1 | $326K | Hold |
2,406
| – | – | 0.02% | 184 |
|
|
2020
Q4 | $308K | Buy |
2,406
+282
| +13% | +$36.1K | 0.03% | 186 |
|
|
2020
Q3 | $239K | Buy |
+2,124
| New | +$239K | 0.03% | 187 |
|
|
2020
Q1 | – | Sell |
-11,793
| Closed | -$625K | – | 536 |
|
|
2019
Q4 | $625K | Sell |
11,793
-3,003
| -20% | -$159K | 0.05% | 329 |
|
|
2019
Q3 | $585K | Hold |
14,796
| – | – | 0.05% | 330 |
|
|
2019
Q2 | $608K | Sell |
14,796
-2,897
| -16% | -$119K | 0.06% | 309 |
|
|
2019
Q1 | $824K | Sell |
17,693
-5,514
| -24% | -$257K | 0.08% | 225 |
|
|
2018
Q4 | $1.01M | Buy |
23,207
+1,582
| +7% | +$68.9K | 0.1% | 199 |
|
|
2018
Q3 | $1.24M | Buy |
+21,625
| New | +$1.24M | 0.1% | 196 |
|